Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × acalabrutinib × Clear all

NCT04198922 2025-11-05

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Phase 2 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms